Rynatan Chewable Pediatric Tablets
Generic name:phenylephrine tannate and chlorpheniramine tannate
Dosage form: chewable tablet
Drug class:Upper respiratory combinations
Medically reviewed by Drugs.com. Last updated on May 23, 2022.
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
On This Page
The Rynatan Pediatric brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Description
Rynatan® Chewable Pediatric Tablets are an antihistamine/nasal decongestant combination. Each grape flavored chewable tablet contains:
Phenylephrine Tannate 5 mg
Chlorpheniramine Tannate 4.5 mg
Other ingredients: FD&C Blue No. 2, FD&C Red No. 40, flavor (artificial), magnesium stearate, maltodextrin, saccharin sodium, sodium starch glycolate, sucrose, talc.
Clinical Pharmacology
Rynatan® Chewable Pediatric Tablets combine the sympathomimetic decongestant effect of phenylephrine with the antihistaminic action of chlorpheniramine.
Indications and Usage
Rynatan® Chewable Pediatric Tablets are indicated for symptomatic relief of the coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease.
Contraindications
Rynatan® Chewable Pediatric Tablets are contraindicated for newborns, nursing mothers and patients sensitive to any of the ingredients or related compounds.
